Enteric Disease Testing Market, By Disease Type (E. coli Infection, Salmonellosis, Campylobacteriosis, Rotavirus Infection, Cryptosporidiosis, Norovirus Infection, Cholera, C. difficile, H. pylori, Amebiasis, Shigellosis), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five each year, and children who survive repeated infections by gut pathogens in the early years of their life may suffer from lifelong health problems. This continuous rise in enteric infections among children is one of the major factors contributing to growth of the enteric disease testing market. Moreover, increasing launch of enteric disease testing products by key manufacturers is expected assist the growth of the market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the Global Enteric Disease Testing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Enteric Disease Testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Enteric Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Enteric Disease Testing market
Detailed Segmentation:
Global Enteric Disease Testing Market, By Disease Type:
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
Global Enteric Disease Testing Market, By Region:
North America
By Disease Type:
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
By Country
U.S.
Canada
Latin America
By Disease Type:
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Disease Type:
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Disease Type:
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Disease Type:
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Disease Type:
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
By Country
North Africa
Central Africa
South Africa
Company Profiles
Alere, Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Becton Dickinson & Company
Biomerica, Inc.
bioMerieux
Bio-Rad
Cepheid
Coris BioConcept
DiaSorin
Meridian Bioscience, Inc.
Quest Diagnostics
Trinity Biotech
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook